Keaveny TM, Guo XE, Wachtel EF, McMahon TA, Hayes WC (1994) Trabecular bone exhibits fully linear elastic behavior and yields at low strains. J Biomech 27:1127–1129PubMedCrossRef 39. Keaveny TM, Wachtel EF, Ford CM,

Hayes WC (1994) Differences between the tensile and compressive strengths of bovine tibial trabecular bone depend on modulus. J Biomech 27:1137–1146PubMedCrossRef 40. Keaveny TM (2001) Strength of trabecular bone. In: Cowin SC (ed) Bone mechanics handbook. CRC, Boca Eltanexor clinical trial Raton, FL ch 16 41. Guo XE, Gibson LJ, McMahon TA (1993) Fatigue of trabecular bone: avoiding end-crushing artifacts. Trans 39th Orthop Res Soc 18:584 42. Keaveny TM, Pinilla TP, Crawford RP, Kopperdahl DL, Lou A (1997) Systematic and random errors in compression testing of trabecular bone. J Orthop Res 15:101–110PubMedCrossRef”
“Erratum to: Osteoporosis International issue 198/20/6 DOI

10.1007/s00198-009-0862-9 The third sentence from the end of the section headed “Human data”, in the right-hand column of page 1099, incorrectly stated: “”In other words, the clearance rate of bone strontium appears to be low”. The correct statement Bafilomycin A1 cell line is: “”In other words, the clearance rate of bone strontium appears to be high”.”
“I first met Pierre Delmas in 1989, when I was a young medical student during a rotation in the division of endocrinology of Edouard Herriot Hospital. He had given a talk while establishing a check details collaborative project on thyroid and bone with his endocrinologist colleagues. I did not know then that he would later be my teacher and mentor in rheumatology, but I was already impressed by the clear mind, the

vision, the rigor, the charisma. Indeed, he was among the few academics with the ability to combine clinical skills, research work and teaching with equal achievement. But what was most striking was his ability to allow his collaborators Axenfeld syndrome to work with great autonomy, yet ensure everything was still supervised rigorously. Everyone’s creativity was stimulated, but also wisely guided. All of us in the group believe that preserving and developing his tremendous intellectual heritage is what he desired. Today, this is possible because he taught us to work independently, his way. This issue of Osteoporosis International is very important to us, because, a year after he left us, we are proud to show with three scientific articles that his legacy is still alive. His lab is working well, we have already achieved important goals and have many projects running. The cohorts will continue, a new one will be recruited soon, and the bone quality research field is expanding. From the clinics to the bench, and from the bench to the clinics was also his creed. Here too, he succeeded so well that, when I see his former patients, they always express deep regret and gratitude. This tribute from patients is certainly the most important point among the many things the bone community has said and written over the past year.